학술논문

Residual macrovascular risk in 2013: what have we learned?
Document Type
TEXT
Source
Subject
Medicine, Health
term fenofibrate therapy
cardiovascular munster procam
residual cardiovascular risk
atherogenic dyslipidaemia
Type 2 diabetes
therapeutic options
high denisty lipoprotein
randomized controlled-trial
coronary artery disease
type-2 diabetes mellitus
triglyceride-rich lipoprotein
alpha/delta agonist GFT505
placebo-controlled trial
Medizin, Gesundheit
phospholipid fatty acids
type 2 diabetes
triglyceride-rich lipoproteins
Language
English